Gelatin methacryloyl hydrogels for musculoskeletal tissue regeneration

Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them...

Descripción completa

Detalles Bibliográficos
Autores: Kim, Yang-Hee, Dawson, Jonathan I., Oreffo, Richard O. C., Tabata, Yasuhiko, Kumar, Dhiraj|||0000-0002-5907-9740, Aparicio Bádenas, Conrado José|||0000-0003-2969-6067, Mutreja, Isha
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Politècnica de Catalunya (UPC)
Repositorio:UPCommons. Portal del coneixement obert de la UPC
Idioma:inglés
OAI Identifier:oai:upcommons.upc.edu:2117/422227
Acceso en línea:https://hdl.handle.net/2117/422227
https://dx.doi.org/10.3390/bioengineering9070332
Access Level:acceso abierto
Palabra clave:Gelatin
GelMA
Hydrogel
Drug delivery
Musculoskeletal tissue
Àrees temàtiques de la UPC::Enginyeria biomèdica
Descripción
Sumario:Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them promising platforms for controlling cell functions. Gelatin methacryloyl (GelMA) hydrogel in particular has been extensively investigated as a promising biomaterial due to its tuneable and beneficial properties and has been widely used in different biomedical applications. In this review, a detailed overview of GelMA synthesis, hydrogel design and applications in regenerative medicine is provided. After summarising recent progress in hydrogels more broadly, we highlight recent advances of GelMA hydrogels in the emerging fields of musculoskeletal drug delivery, involving therapeutic drugs (e.g., growth factors, antimicrobial molecules, immunomodulatory drugs and cells), delivery approaches (e.g., single-, dual-release system), and material design (e.g., addition of organic or inorganic materials, 3D printing). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications.